COGT Cogent Biosciences, Inc. - Common Stock
COGT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
COGT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
COGT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 8 42,1%
- Compra 8 42,1%
- Mantieni 3 15,8%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
12 analisti · 2026-08-16Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-0.60 | $-0.55 | -0.05% |
| 31 Dicembre 2025 | $-0.64 | $-0.53 | -0.11% |
| 30 Settembre 2025 | $-0.50 | $-0.54 | 0.04% |
| 30 Giugno 2025 | $-0.53 | $-0.60 | 0.07% |
| 31 Marzo 2025 | $-0.52 | $-0.60 | 0.08% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $8M | $22M | $10M | $8M | |
| R&D Expense | $270M | $233M | $174M | $122M | $56M | $26M | $44M | $38M | $30M | |
| SG&A Expense | $64M | $43M | $34M | $26M | $20M | $17M | $11M | $7M | $5M | |
| Operating Expenses | $333M | $276M | $208M | $148M | $76M | $90M | $55M | $46M | $35M | |
| Operating Income | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | $-26M | |
| Interest Income | $15M | $18M | $13M | $4M | $467.0K | $144.0K | $267.0K | $1M | $386.0K | |
| Other Non-op | $-20.0K | $2M | $943.0K | $2M | $3M | $7M | $345.0K | $320.0K | $274.0K | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | $-25M | |
| EPS (Basic) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| EPS (Diluted) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| Shares (Basic) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| Shares (Diluted) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| EBITDA | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | · |
Stato Patrimoniale 22
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $312M | $98M | $53M | $140M | $220M | $242M | $37M | $56M | $28M | |
| Short-term Investments | · | · | · | · | · | · | · | $23M | $13M | |
| Receivables | · | · | · | · | · | · | $2M | $2M | $830.0K | |
| Prepaid Expense | $10M | $9M | $5M | $4M | $3M | $3M | $1M | $740.0K | $513.0K | |
| Current Assets | $910M | $296M | $271M | $265M | $223M | $245M | $41M | $81M | $42M | |
| PP&E (Net) | $5M | $6M | $8M | $8M | $2M | $134.0K | $2M | $3M | $4M | |
| PP&E (Gross) | $14M | $13M | $12M | $9M | $2M | $546.0K | $6M | $7M | $6M | |
| Accum. Depreciation | $9M | $6M | $4M | $1M | $559.0K | $412.0K | $5M | $3M | $2M | |
| Other Non-current Assets | $3M | $5M | $5M | $5M | $4M | · | $427.0K | $419.0K | · | |
| Total Assets | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Accounts Payable | $10M | $12M | $11M | $6M | $3M | $732.0K | $3M | $2M | $1M | |
| Current Liabilities | $64M | $56M | $38M | $27M | $17M | $13M | $13M | $25M | $11M | |
| Capital Leases | $14M | $16M | $17M | $18M | $831.0K | $3M | $4M | · | · | |
| Other Non-current Liabilities | $33.0K | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $301M | $72M | $56M | $45M | $18M | $16M | $18M | $26M | $21M | |
| Long-term Debt | $223M | · | · | · | · | · | · | · | · | |
| Common Stock | $161.0K | $110.0K | $86.0K | $70.0K | $44.0K | $32.0K | $8.0K | $30.0K | $10.0K | |
| Retained Earnings | $-1.19B | $-859M | $-604M | $-411M | $-271M | $-199M | $-124M | $-92M | $-51M | |
| AOCI | $355.0K | $447.0K | $246.0K | $-104.0K | · | · | · | $-12.0K | $-16.0K | |
| Stockholders' Equity | $636M | $256M | $258M | $256M | $214M | $235M | $32M | $60M | $-49M | |
| Liabilities + Equity | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Shares Outstanding | 160,980,024 | 110,461,729 | 86,124,249 | 69,893,434 | 43,805,922 | 32,347,905 | 7,665,763 | 30,057,970 | 10,201,690 |
Flusso di cassa 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $800.0K | $147.0K | $720.0K | $1M | $1M | $1M | |
| Stock-based Comp | $46M | $40M | $31M | $18M | $12M | $6M | $3M | $3M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | $4M | · | · | · | |
| Operating Cash Flow | $-264M | $-208M | $-154M | $-119M | $-59M | $-36M | $-42M | $-32M | $-26M | |
| CapEx | $2M | $573.0K | $3M | $7M | $2M | · | $33.0K | $549.0K | $912.0K | |
| Investing Cash Flow | $-400M | $38M | $-98M | $-125M | $-2M | $8M | $23M | $-11M | $14M | |
| Debt Issued | $49M | $0 | $0 | · | · | · | · | · | · | |
| Net Debt Issued | $49M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $162M | $0 | $0 | $25M | $108.0K | $609.0K | $60.0K | |
| Net Stock Activity | · | $0 | $162M | · | · | $25M | $108.0K | $609.0K | · | |
| Financing Cash Flow | $878M | $214M | $164M | $164M | $38M | $232M | $108.0K | $70M | $-729.0K | |
| Net Change in Cash | $214M | $45M | $-88M | $-80M | $-23M | $205M | $-18M | $27M | $-13M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-266M | $-208M | $-156M | $-126M | $-60M | · | $-42M | $-33M | · |
Redditività 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| Net Margin | · | · | · | · | · | -950.4% | -141.5% | -354.8% | · | |
| EBITDA Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| ROA | -52.0% | -79.8% | -62.6% | -52.6% | -29.9% | -49.8% | -47.0% | -51.1% | · | |
| ROE | -83.1% | -89.6% | -68.6% | -51.4% | -35.1% | -70.4% | -105.4% | -54.1% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 | 18.7 | 3.1 | 3.2 | · | |
| Quick Ratio | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 | 18.5 | 3.0 | 3.2 | · |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.1 | 0.3 | 0.1 | · | |
| Receivables Turnover | · | · | · | · | · | · | 12.3 | 7.8 | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | $23M | $23M | $23M | $23M | $8M | $22M | $10M | · | |
| Net Income TTM | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | · | |
| Market Cap | $5.72B | $862M | $506M | $808M | $376M | $363M | $88M | $529M | · | |
| P/E | -16.4 | -4.0 | -3.0 | -6.7 | -4.6 | -10.7 | -2.7 | -11.0 | · | |
| P/S | 246.9 | 37.2 | 21.9 | 34.9 | 16.2 | 46.2 | 3.9 | 54.3 | · | |
| P/B | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | 2.8 | 8.8 | · | |
| P / Tangible Book | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | · | · | · | |
| P / Cash Flow | -21.6 | -4.1 | -3.3 | -6.8 | -6.4 | -10.1 | -2.1 | -16.3 | · | |
| P / FCF | -21.5 | -4.1 | -3.2 | -6.4 | -6.2 | · | -2.1 | -16.0 | · | |
| Earnings Yield | -6.1% | -24.9% | -33.0% | -15.0% | -21.8% | -9.3% | -36.5% | -9.1% | · |
Conto Economico 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $71M | $75M | $76M | $69M | $62M | $63M | $62M | $64M | $54M | $53M | $49M | $50M | $39M | $36M | $37M | $30M | |
| SG&A Expense | $32M | $28M | $24M | $14M | $13M | $12M | $12M | $12M | $10M | $10M | $10M | $9M | $8M | $7M | $7M | $7M | |
| Operating Expenses | $103M | $104M | $99M | $83M | $76M | $75M | $74M | $75M | $64M | $62M | $58M | $60M | $47M | $43M | $44M | $37M | |
| Operating Income | $-103M | $-104M | $-99M | $-83M | $-76M | $-75M | $-74M | $-75M | $-64M | $-62M | $-58M | $-60M | $-47M | $-43M | $-44M | $-37M | |
| Interest Income | $7M | $8M | $5M | $4M | $2M | $3M | $4M | $5M | $5M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Other Non-op | $-11.0K | $-140.0K | $-6.0K | $-3.0K | $-6.0K | $-5.0K | $2M | $1.0K | $44.0K | $-1.0K | $-7.0K | $0 | $268.0K | $682.0K | $-1M | $2M | |
| Net Income | $-96M | $-97M | $-102M | $-81M | $-74M | $-72M | $-68M | $-71M | $-59M | $-58M | $-54M | $-55M | $-44M | $-39M | $-40M | $-35M | |
| EPS (Basic) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.16 | $-0.64 | $-0.59 | $-0.55 | $0.16 | $-0.50 | |
| EPS (Diluted) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.16 | $-0.64 | $-0.59 | $-0.55 | $0.16 | $-0.50 | |
| Shares (Basic) | 171,005,468 | 162,194,778 | -236,424,771 | 137,550,159 | 114,466,080 | 113,307,940 | -200,353,658 | 110,165,580 | 99,240,030 | 94,804,659 | -151,996,228 | 86,165,951 | 74,753,269 | 70,734,950 | -105,331,505 | 69,576,359 | |
| Shares (Diluted) | 171,005,468 | 162,194,778 | -236,424,771 | 137,550,159 | 114,466,080 | 113,307,940 | -200,353,658 | 110,165,580 | 99,240,030 | 94,804,659 | -151,996,228 | 86,165,951 | 74,753,269 | 70,734,950 | -105,331,505 | 69,576,359 | |
| EBITDA | $-103M | $-104M | · | $-83M | $-76M | $-75M | · | $-75M | $-64M | $-62M | · | $-60M | $-47M | $-43M | · | $-37M |
Stato Patrimoniale 21
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $181M | $241M | $312M | $125M | $128M | $126M | $98M | $97M | $88M | $216M | · | $87M | $214M | $161M | · | $141M | |
| Prepaid Expense | $13M | $11M | $10M | $6M | $7M | $7M | $9M | $6M | $7M | $6M | · | $7M | $5M | $5M | · | $6M | |
| Current Assets | $805M | $878M | $910M | $397M | $245M | $253M | $296M | $342M | $370M | $442M | · | $286M | $335M | $226M | · | $296M | |
| PP&E (Net) | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $8M | · | $9M | $9M | $9M | · | $7M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $13M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $5M | |
| Total Assets | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | · | $355M | $392M | $263M | · | $332M | |
| Accounts Payable | $7M | $14M | $10M | $16M | $17M | $14M | $12M | $15M | $9M | $16M | · | $10M | $7M | $4M | · | $4M | |
| Current Liabilities | $59M | $58M | $64M | $62M | $58M | $49M | $56M | $53M | $40M | $37M | · | $35M | $26M | $21M | · | $24M | |
| Capital Leases | $19M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $17M | $17M | · | $18M | $18M | $19M | · | $18M | |
| Other Non-current Liabilities | $90.0K | $62.0K | $33.0K | $2M | $2M | $5.0K | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $302M | $295M | $301M | $123M | $120M | $65M | $72M | $69M | $57M | $54M | · | $53M | $44M | $40M | · | $42M | |
| Long-term Debt | $223M | $223M | $223M | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $171.0K | $171.0K | $161.0K | $141.0K | $114.0K | $114.0K | $110.0K | $110.0K | $109.0K | $96.0K | · | $86.0K | $85.0K | $71.0K | · | $70.0K | |
| Retained Earnings | $-1.38B | $-1.29B | $-1.19B | $-1.09B | $-1.00B | $-931M | $-859M | $-792M | $-721M | $-662M | · | $-549M | $-494M | $-450M | · | $-372M | |
| AOCI | $-770.0K | $-415.0K | $355.0K | $208.0K | $13.0K | $164.0K | $447.0K | $896.0K | $-192.0K | $-39.0K | · | $-172.0K | $-97.0K | $16.0K | · | $-163.0K | |
| Stockholders' Equity | $532M | $608M | $636M | $302M | $155M | $219M | $256M | $315M | $373M | $422M | $258M | $303M | $348M | $224M | $256M | $290M | |
| Liabilities + Equity | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | · | $355M | $392M | $263M | · | $332M | |
| Shares Outstanding | 171,598,409 | 170,773,803 | 160,980,024 | 139,827,662 | 113,928,492 | 113,856,454 | 110,461,729 | 110,458,249 | 109,343,224 | 95,613,396 | · | 86,124,249 | 85,334,165 | 70,946,790 | · | 69,857,972 |
Flusso di cassa 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $741.0K | $626.0K | $664.0K | $641.0K | $655.0K | $640.0K | $675.0K | $620.0K | $606.0K | $599.0K | $628.0K | $581.0K | $562.0K | $529.0K | $378.0K | $256.0K | |
| Stock-based Comp | $17M | $17M | $16M | $11M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $9M | $7M | $6M | $5M | $5M | |
| Operating Cash Flow | $-77M | $-87M | $-79M | $-64M | $-55M | $-67M | $-61M | $-52M | $-43M | $-53M | $-44M | $-38M | $-32M | $-40M | $-29M | $-34M | |
| CapEx | $370.0K | $449.0K | $811.0K | $65.0K | $131.0K | $547.0K | $75.0K | $280.0K | $148.0K | $70.0K | $315.0K | $121.0K | $1M | $1M | $2M | $3M | |
| Investing Cash Flow | $14M | $-36M | $-323M | $-155M | $9M | $69M | $62M | $60M | $-85M | $1M | $10M | $-91M | $-78M | $60M | $28M | $-152M | |
| Debt Issued | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | · | $-170.0K | · | · | · | · | |
| Financing Cash Flow | $3M | $53M | $589M | $217M | $47M | $25M | $26.0K | $624.0K | $-256.0K | $214M | $0 | $1M | $162M | $445.0K | $315.0K | $990.0K | |
| Net Change in Cash | $-60M | $-71M | $187M | $-2M | $2M | $28M | $1M | $9M | $-128M | $163M | $-34M | $-128M | $52M | $21M | $-682.0K | $-185M | |
| Free Cash Flow | · | $-87M | · | · | · | $-67M | · | · | · | $-53M | · | · | · | $-41M | · | · |
Redditività 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -17.4% | -16.4% | · | -20.0% | -20.9% | -18.9% | · | -19.1% | -14.3% | -15.8% | · | -16.1% | -11.6% | -16.4% | · | -12.8% | |
| ROE | -28.1% | -23.5% | · | -26.2% | -27.8% | -22.4% | · | -22.9% | -16.3% | -18.1% | · | -18.7% | -13.2% | -18.8% | · | -14.4% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 15.1 | · | 6.4 | 4.2 | 5.1 | · | 6.4 | 9.2 | 12.0 | · | 8.2 | 13.0 | 10.7 | · | 12.6 | |
| Quick Ratio | 3.1 | 4.2 | · | 2.0 | 2.2 | 2.6 | · | 1.8 | 2.2 | 5.9 | · | 2.5 | 8.3 | 7.6 | · | 6.0 | |
| Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | $23M | · | $23M | $23M | $23M | · | $23M | $23M | $23M | · | $23M | $23M | $23M | · | $23M | |
| Net Income TTM | $-348M | $-324M | · | $-297M | $-275M | $-260M | · | $-243M | $-217M | $-196M | · | $-173M | $-153M | $-139M | · | $-120M | |
| Market Cap | $6.64B | $6.57B | · | $2.01B | $818M | $682M | · | $1.19B | $922M | $643M | · | $840M | $1.01B | $766M | · | $1.04B | |
| Enterprise Value | · | · | · | $1.93B | $734M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -18.6 | -18.5 | · | -6.9 | -3.6 | -3.1 | · | -5.2 | -3.9 | -3.0 | · | -4.3 | -5.0 | -4.4 | · | -6.3 | |
| P/S | 286.8 | 283.8 | · | 86.7 | 35.3 | 29.4 | · | 51.5 | 39.8 | 27.7 | · | 36.3 | 43.6 | 33.1 | · | 45.0 | |
| P/B | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | · | 2.8 | 2.9 | 3.4 | · | 3.6 | |
| P / Tangible Book | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | · | 2.8 | 2.9 | 3.4 | · | 3.6 | |
| P / Cash Flow | · | -75.7 | · | · | · | -10.3 | · | · | · | -12.2 | · | · | · | -19.4 | · | · | |
| P / FCF | · | -75.3 | · | · | · | -10.2 | · | · | · | -12.2 | · | · | · | -18.8 | · | · | |
| EV / EBITDA | · | · | · | -23.1 | -9.7 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 83.2 | 31.7 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -5.4% | -5.4% | · | -14.4% | -27.9% | -32.7% | · | -19.3% | -25.5% | -33.8% | · | -23.4% | -19.9% | -22.6% | · | -15.9% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utile netto | $-329M | $-256M | $-192M | $-140M | $-72M |
| EPS Diluito | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 |
| Quick Ratio | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-266M | $-208M | $-156M | $-126M | $-60M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 342 filer · $5.5B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 71 (-11 vs trimestre precedente) | 41 (+7 vs trimestre precedente) | 119 (+7 vs trimestre precedente) | 93 (+10 vs trimestre precedente) | +2.8M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $868.722.546 | 22.447.611 | 15,68% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $312.402.306 | 8.072.411 | 5,64% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $286.857.171 | 7.412.330 | 5,18% | Azioni |
| STATE STREET CORP | $269.542.365 | 6.964.919 | 4,87% | Azioni |
| Fairmount Funds Management LLC | $212.982.277 | 5.503.418 | 3,84% | Azioni |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $193.736.225 | 5.006.104 | 3,50% | Azioni |
| TCG Crossover Management, LLC | $187.866.673 | 4.854.436 | 3,39% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $150.424.045 | 3.885.979 | 2,72% | Azioni |
| Kynam Capital Management, LP | $141.916.654 | 3.667.097 | 2,56% | Azioni |
| Polar Capital Holdings Plc | $125.113.424 | 3.232.905 | 2,26% | Azioni |
| Commodore Capital LP | $118.035.000 | 3.050.000 | 2,13% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $108.741.040 | 2.809.846 | 1,96% | Azioni |
| Woodline Partners LP | $100.742.369 | 2.603.162 | 1,82% | Azioni |
| Pictet Asset Management Holding SA | $92.634.023 | 2.393.515 | 1,67% | Azioni |
| Octagon Capital Advisors LP | $90.945.000 | 2.350.000 | 1,64% | Azioni |
| RTW INVESTMENTS, LP | $89.359.113 | 2.309.021 | 1,61% | Azioni |
| Candriam S.C.A. | $80.742.121 | 2.088.369 | 1,46% | Azioni |
| Deep Track Capital, LP | $77.400.000 | 2.000.000 | 1,40% | Azioni |
| Siren, L.L.C. | $71.954.097 | 1.859.279 | 1,30% | Azioni |
| ORBIMED ADVISORS LLC | $65.066.310 | 1.681.300 | 1,17% | Azioni |
| Venrock Adviser, LLC | $63.551.824 | 1.642.166 | 1,15% | Azioni |
| GOLDMAN SACHS GROUP INC | $63.052.788 | 1.629.271 | 1,14% | Azioni |
| EMERALD ADVISERS, LLC | $62.048.445 | 1.603.319 | 1,12% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $56.087.910 | 1.449.300 | 1,01% | Azioni |
| Assenagon Asset Management S.A. | $55.795.957 | 1.441.756 | 1,01% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $55.455.537 | 1.432.957 | 1,00% | Azioni |
| SILVERARC CAPITAL MANAGEMENT, LLC | $49.563.361 | 1.280.707 | 0,89% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $46.962.837 | 1.213.510 | 0,85% | Azioni |
| Elmind Capital, LP | $45.307.638 | 1.170.740 | 0,82% | Azioni |
| FRED ALGER MANAGEMENT, LLC | $41.518.521 | 1.072.830 | 0,75% | Azioni |
| Sofinnova Investments, Inc. | $40.060.228 | 1.035.148 | 0,72% | Azioni |
| EMERALD MUTUAL FUND ADVISERS TRUST | $39.914.329 | 1.031.378 | 0,72% | Azioni |
| BANK OF AMERICA CORP /DE/ | $38.680.534 | 999.497 | 0,70% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $38.551.702 | 996.168 | 0,70% | Azioni |
| Balyasny Asset Management L.P. | $36.952.424 | 954.843 | 0,67% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $35.128.454 | 907.712 | 0,63% | Azioni |
| Logos Global Management LP | $34.830.000 | 900.000 | 0,63% | Azioni |
| Squadron Capital Management LLC | $33.475.500 | 865.000 | 0,60% | Azioni |
| CITADEL ADVISORS LLC | $32.883.158 | 849.694 | 0,59% | Azioni |
| D. E. Shaw & Co., Inc. | $29.941.106 | 773.672 | 0,54% | Azioni |
| Point72 Asset Management, L.P. | $28.800.347 | 744.195 | 0,52% | Azioni |
| MARSHALL WACE, LLP | $27.328.122 | 706.153 | 0,49% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $26.812.328 | 692.825 | 0,48% | Azioni |
| J. Goldman & Co LP | $24.690.368 | 637.994 | 0,45% | Azioni |
| First Turn Management, LLC | $23.308.275 | 602.281 | 0,42% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $23.119.380 | 597.400 | 0,42% | Opzione Call |
| ALLIANCEBERNSTEIN L.P. | $22.042.992 | 572.694 | 0,40% | Azioni |
| Rock Springs Capital Management LP | $19.965.988 | 515.917 | 0,36% | Azioni |
| Redmile Group, LLC | $19.478.523 | 503.321 | 0,35% | Azioni |
| DIADEMA PARTNERS LP | $19.104.797 | 493.664 | 0,34% | Azioni |
| Eversept Partners, LP | $18.972.094 | 490.235 | 0,34% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $17.776.458 | 459.340 | 0,32% | Azioni |
| Ensign Peak Advisors, Inc | $17.697.587 | 457.302 | 0,32% | Azioni |
| Affinity Asset Advisors, LLC | $17.415.000 | 450.000 | 0,31% | Azioni |
| BlackRock, Inc. | $16.916.738 | 437.125 | 0,31% | Azioni |
| Patient Square Capital LP | $16.447.500 | 425.000 | 0,30% | Azioni |
| SEGALL BRYANT & HAMILL, LLC | $16.300.711 | 421.207 | 0,29% | Azioni |
| AMERIPRISE FINANCIAL INC | $16.177.723 | 418.029 | 0,29% | Azioni |
| Defilade Capital Management, L.P. | $15.226.167 | 393.441 | 0,27% | Azioni |
| Aberdeen Group plc | $15.218.156 | 393.234 | 0,27% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15.189.000 | 392.484 | 0,27% | Azioni |
| Ikarian Capital, LLC | $14.322.251 | 370.084 | 0,26% | Azioni |
| KENNEDY CAPITAL MANAGEMENT LLC | $13.691.673 | 353.790 | 0,25% | Azioni |
| SUPERSTRING CAPITAL MANAGEMENT LP | $13.285.091 | 343.284 | 0,24% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $12.861.326 | 332.334 | 0,23% | Azioni |
| Burkehill Global Management, LP | $12.577.500 | 325.000 | 0,23% | Azioni |
| FEDERATED HERMES, INC. | $10.951.287 | 282.979 | 0,20% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10.799.854 | 279.066 | 0,19% | Azioni |
| Alyeska Investment Group, L.P. | $10.636.656 | 274.849 | 0,19% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $9.918.346 | 256.288 | 0,18% | Azioni |
| Parkman Healthcare Partners LLC | $9.805.226 | 253.365 | 0,18% | Azioni |
| Evergreen Quality Fund GP, Ltd. | $9.675.000 | 250.000 | 0,17% | Azioni |
| Swiss National Bank | $9.535.680 | 246.400 | 0,17% | Azioni |
| Russell Investments Group, Ltd. | $8.936.487 | 230.917 | 0,16% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $8.891.519 | 229.755 | 0,16% | Azioni |
| F/m Investments LLC | $8.850.226 | 228.688 | 0,16% | Azioni |
| SEB Asset Management AB | $8.827.182 | 228.093 | 0,16% | Azioni |
| PEREGRINE CAPITAL MANAGEMENT LLC | $8.759.745 | 226.350 | 0,16% | Azioni |
| Boxer Capital Management, LLC | $8.707.500 | 225.000 | 0,16% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $8.673.289 | 224.116 | 0,16% | Azioni |
| Exome Asset Management LLC | $8.147.240 | 210.523 | 0,15% | Azioni |
| RHUMBLINE ADVISERS | $8.034.456 | 207.609 | 0,15% | Azioni |
| Integral Health Asset Management, LLC | $7.740.000 | 200.000 | 0,14% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.472.970 | 193.100 | 0,13% | Opzione Put |
| Pier Capital, LLC | $7.312.404 | 188.951 | 0,13% | Azioni |
| HighVista Strategies LLC | $7.305.786 | 188.780 | 0,13% | Azioni |
| Jefferies Financial Group Inc. | $7.281.753 | 188.159 | 0,13% | Azioni |
| Fisher Asset Management, LLC | $7.154.661 | 184.875 | 0,13% | Azioni |
| Caption Management, LLC | $7.124.670 | 184.100 | 0,13% | Opzione Call |
| SummitTX Capital, L.P. | $6.955.706 | 179.734 | 0,13% | Azioni |
| OSTERWEIS CAPITAL MANAGEMENT INC | $6.659.690 | 172.085 | 0,12% | Azioni |
| CITIGROUP INC | $6.611.315 | 170.835 | 0,12% | Azioni |
| Qube Research & Technologies Ltd | $6.547.963 | 169.198 | 0,12% | Azioni |
| Schonfeld Strategic Advisors LLC | $6.544.672 | 169.113 | 0,12% | Azioni |
| Man Group plc | $6.496.105 | 167.858 | 0,12% | Azioni |
| VOYA INVESTMENT MANAGEMENT LLC | $6.491.112 | 167.729 | 0,12% | Azioni |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $6.174.392 | 159.545 | 0,11% | Azioni |
| Nuveen, LLC | $6.140.258 | 158.663 | 0,11% | Azioni |
| Atika Capital Management LLC | $6.130.970 | 158.423 | 0,11% | Azioni |
| WELLS FARGO & COMPANY/MN | $6.096.256 | 157.526 | 0,11% | Azioni |
Insider aziendali 25 insider · 11 dirigenti · 13 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Andrew R Robbins | President and CEO | 19 Maggio 2026 G | 160.000 | 0 | 0 | $0 |
| Charles Wilson | Chief Executive Officer | 01 Marzo 2019 A | — | 0 | 0 | $0 |
| John L. Green | Chief Financial Officer | 26 Dicembre 2025 S | 131.834 | 0 | 1 | $-2.978.360 |
| Matthew Scott Osborne | Chief Financial Officer | 11 Febbraio 2020 A | — | 0 | 0 | $0 |
| John Edward Robinson | Chief Scientific Officer | 26 Dicembre 2025 S | 140.002 | 0 | 1 | $-3.486.600 |
| Jessica Sachs | Chief Medical Officer | 26 Dicembre 2025 S | 133.938 | 0 | 1 | $-3.198.245 |
| Evan Kearns | Chief Legal Officer | 26 Dicembre 2025 S | 109.398 | 0 | 1 | $-2.515.500 |
| Cole Pinnow | Chief Commercial Officer | 17 Dicembre 2025 A | 216.650 | 0 | 0 | $0 |
| Geoffrey Hodge | Chief Technical Officer | 11 Febbraio 2020 A | — | 0 | 0 | $0 |
| Seth Ettenberg | Chief Scientific Officer | 11 Febbraio 2020 A | 0 | 0 | 0 | $0 |
| Michael Vasconcelles | Chief Medical Officer | 01 Marzo 2019 A | — | 0 | 0 | $0 |
| Karen Jean Ferrante | Direttore | 01 Luglio 2026 A | — | 0 | 0 | $0 |
| Christopher W. Cain | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Todd Shegog | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Matthew Ros | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Peter Harwin | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Arlene Morris | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Fairmount Funds Management LLC | Direttore | 31 Marzo 2026 C | 5.503.418 | 0 | 2 | $-370.020.000 |
| Jorn Aldag | Direttore | 01 Luglio 2020 A | — | 0 | 0 | $0 |
| Bruce Booth | Direttore | 01 Luglio 2020 A | 3.361.535 | 0 | 0 | $0 |
| Liam Ratcliffe | Direttore | 14 Giugno 2019 A | 897.773 | 0 | 0 | $0 |
| Robert J Perez | Direttore | 14 Giugno 2019 A | — | 0 | 0 | $0 |
| Dario Campana | Proprietario del 10% | 12 Maggio 2020 S | 3.095.114 | 0 | 0 | $0 |
| FIL Ltd | — | 03 Aprile 2018 C | 1.138.274 | 0 | 0 | $0 |
| FMR LLC | — | 03 Aprile 2018 C | 23.240 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×11 depositi | 31 Marzo 2026 | 8,60% | Modifica | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 46 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 7,53% | 226.142 NS | 31 Maggio 2026 | N-PORT |
| CANC · Tema ETF Trust | 4,10% | 206.419 NS | 31 Maggio 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 2,85% | 33.428 NS | 31 Maggio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 134.554 NS | 30 Aprile 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,63% | 6.554 NS | 30 Aprile 2026 | N-PORT |
| ESSC · Strategy Shares | 0,42% | 3.026 NS | 30 Aprile 2026 | N-PORT |
| BIB · ProShares Trust | 0,28% | 6.002 NS | 31 Maggio 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,25% | 89.450 NS | 30 Aprile 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 45.155 NS | 30 Aprile 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 4.161 NS | 30 Aprile 2026 | N-PORT |
| RSSL · Global X Funds | 0,16% | 62.036 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,13% | 6.734 NS | 31 Maggio 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,11% | 738.864 NS | 31 Maggio 2026 | N-PORT |
| UWM · ProShares Trust | 0,07% | 5.268 NS | 31 Maggio 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,06% | 17.403 NS | 31 Maggio 2026 | N-PORT |
| URTY · ProShares Trust | 0,05% | 5.326 NS | 31 Maggio 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 147 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 38.351 NS | 30 Aprile 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,03% | 5.488 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 134 NS | 31 Maggio 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 42.596 NS | 31 Maggio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 5.513 NS | 30 Aprile 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 92.899 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VBR · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Luglio 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 15 Luglio 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| ITOT · iShares Trust | — | — | 05 Agosto 2026 | Giornaliero |
| IWV · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 23 Luglio 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | — | — | 20 Luglio 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | — | — | 30 Luglio 2026 | Giornaliero |
| ISCB · iShares Trust | — | — | 05 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | — | — | 05 Agosto 2026 | Giornaliero |
| SMLF · iShares Trust | — | — | 10 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | — | — | 14 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | — | — | 05 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 Luglio 2026 | Giornaliero |